loadpatents
name:-0.017804861068726
name:-0.008512020111084
name:-0.0063190460205078
Skokos; Dimitris Patent Filings

Skokos; Dimitris

Patent Applications and Registrations

Patent applications and USPTO patent grants for Skokos; Dimitris.The latest application filed is for "anti-gitr antibodies and uses thereof".

Company Profile
6.11.14
  • Skokos; Dimitris - New York NY
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof
Grant 11,453,721 - Murphy , et al. September 27, 2
2022-09-27
Anti-GITR antibodies and uses thereof
Grant 11,414,494 - Delfino , et al. August 16, 2
2022-08-16
Bispecific anti-CD28 .times. anti-CD22 antibodies and uses thereof
Grant 11,396,544 - Murphy , et al. July 26, 2
2022-07-26
Anti-gitr Antibodies And Uses Thereof
App 20210340267 - Babb; Robert ;   et al.
2021-11-04
Anti-gitr Antibodies And Uses Thereof
App 20210147565 - Delfino; Frank ;   et al.
2021-05-20
EGFR x CD28 MULTISPECIFIC ANTIBODIES
App 20200299388 - Skokos; Dimitris ;   et al.
2020-09-24
Anti-GITR antibodies and uses thereof
Grant 10,738,126 - Delfino , et al. A
2020-08-11
Bispecific Anti-cd28 X Anti-cd22 Antibodies And Uses Thereof
App 20200239576 - Murphy; Andrew J. ;   et al.
2020-07-30
Bispecific Anti-muc16 X Anti-cd28 Antibodies And Uses Thereof
App 20200199233 - Murphy; Andrew J. ;   et al.
2020-06-25
Bispecific Anti-psma X Anti-cd28 Antibodies And Uses Thereof
App 20190389951 - Murphy; Andrew J. ;   et al.
2019-12-26
Anti-gitr Antibodies And Uses Thereof
App 20170355774 - Delfino; Frank ;   et al.
2017-12-14
Combination Of Anti-pd-1 Antibodies And Radiation To Treat Cancer
App 20170327567 - SKOKOS; Dimitris ;   et al.
2017-11-16
Human Antibodies To Human Tnf-like Ligand 1a (tl1a)
App 20170096491 - Classon; Brendan J. ;   et al.
2017-04-06
Method of treating a TL1A-associated disease or disorder with human antibodies to TL1A
Grant 9,556,277 - Classon , et al. January 31, 2
2017-01-31
Methods of treating diabetes with Dll4 antagonists
Grant 8,889,133 - Skokos November 18, 2
2014-11-18
Methods of Treating Autoimmune Diseases with DLL4 Antagonists
App 20140255429 - Skokos; Dimitris
2014-09-11
Methods of treating autoimmune diseases with Dll4 antagonists
Grant 8,765,125 - Skokos July 1, 2
2014-07-01
Human Antibodies to Human TNF-Like Ligand 1A (TL1A)
App 20140120109 - Classon; Brendan J. ;   et al.
2014-05-01
Human antibodies to human TNF-like ligand 1A (TL1A)
Grant 8,642,741 - Classon , et al. February 4, 2
2014-02-04
Human Antibodies To Human Tnf-like Ligand 1a (tl1a)
App 20120114654 - Classon; Brendan J. ;   et al.
2012-05-10
Methods Of Treating Autoimmune Diseases With Dll4 Antagonists
App 20110189200 - SKOKOS; Dimitris
2011-08-04
Methods Of Treating Diseases With Dll4 Antagonists
App 20110189176 - SKOKOS; Dimitris
2011-08-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed